About
Cancer Treatments
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (31)
View allTotal Trials
31
As Lead Sponsor
10
As Collaborator
21
Total Enrollment
4,282
By Phase
PHASE2: 11PHASE4: 1PHASE1: 6NA: 4PHASE2/PHASE3: 2PHASE3: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 15RECRUITING: 6UNKNOWN: 3WITHDRAWN: 3TERMINATED: 3ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline31 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06555133Collaborator
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
PHASE2Recruiting
18 participants
Started: Apr 7, 2025 · Completed: Sep 1, 2029
NCT05655949Collaborator
Y-90 With Durvalumab/Gem/Cis in Intrahepatic Cholangio
PHASE2Recruiting
30 participants
Started: Feb 13, 2024 · Completed: Dec 1, 2027
NCT06035952Lead Sponsor
Study of 3D Scanning for Adolescent Scoliosis
N/AUnknown
70 participants
Started: Aug 7, 2023 · Completed: Dec 15, 2023
NCT05967143Lead Sponsor
Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)
N/ARecruiting
845 participants
Started: Jun 19, 2023 · Completed: Jun 30, 2029
NCT05848947Lead Sponsor
SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA
PHASE4Completed
5 participants
Started: Apr 25, 2023 · Completed: Jul 5, 2023
Locations (1)
Headquarters
Bonn, Germany
Map
Loading map...